Inhance 3D Velocity depicts colorcodedarterial and venous flow inbrain without administration ofcontrast media.
Inhance 3D Velocity depicts colorcoded arterial and venous flow in brain without administration of contrast media. Phase-contrast sequence, optimized to run on GE Healthcare’s high-end 3T Discovery MR750 and 1.5T Discovery MR450, is especially suited for use in patients who may be susceptible to gadolinium- linked nephrogenic systemic fibrosis. (Provided by GE Healthcare)
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.